Assessment of the impacts of public health and social measures on influenza activity during the COVID-19 pandemic from 2020 to 2022 in Beijing, China: a modelling study.

Publication date: Jan 31, 2025

Understanding the impact of public health and social measures (PHSMs) on influenza transmission is crucial for developing effective influenza prevention and control strategies. This modeling study analyzed data from 2017 to 2022, in Beijing, China. Weekly influenza positive rate and influenza-like rate were incorporated to quantify the community-level influenza activities. The effective reproduction number and influenza attack rate were estimated using a branching process model and a transmission dynamics model, respectively. The impact of PHSMs was quantified through log-linear regression and counterfactual simulations under varying PHSM scenarios. The transmissibility of influenza decreased by 68. 41% (95%CI: 52. 43, 78. 80) in 2020, 67. 07% (95%CI: 50. 80, 77. 89) in 2021 and 79. 08% (95%CI: 63. 18, 88. 06) in 2022, and the attack rate dropped by 93. 47% (95%CI: 85. 86, 95. 78), 95. 37% (95%CI: 94. 30, 96. 89) and 71. 61% (95%CI: 42. 96, 81. 24) over the same period, primarily due to the PHSMs. The simulation shows that strict PHSMs effectively suppressed the current flu epidemic effectively. When susceptible individuals drop to 50%, a relaxed strategy results in a smaller rebound in the next flu season, with epidemic sizes increasing to 1. 18 (1. 10, 1. 30), 1. 41 (1. 20, 1. 54), and 1. 54 (1. 35, 1. 55) for relaxed, moderate, and strict measures, respectively. Our study confirms the suppressive effect of coronavirus disease 2019 PHSMs on influenza transmission in Beijing. However, the relaxation of these measures’ triggers resurgence, emphasizing the need for adaptive control strategies tailored to the population susceptibility and epidemic dynamics.

Open Access PDF

Concepts Keywords
China Adolescent
Covid Adult
Influenza Attack rate
Rebound Beijing
Child
China
COVID-19
Humans
Influenza
Influenza, Human
Middle Aged
Pandemics
Public Health
SARS-CoV-2
Transmission dynamics model

Semantics

Type Source Name
disease MESH influenza
disease MESH COVID-19 pandemic
pathway REACTOME Reproduction
disease IDO process
disease IDO susceptibility
disease MESH Infectious Diseases
disease MESH infection
drug DRUGBANK Coenzyme M
pathway REACTOME Infectious disease
disease IDO infectious disease
disease MESH emergencies
drug DRUGBANK Ademetionine
disease MESH virus infections
drug DRUGBANK Trestolone
disease IDO algorithm
drug DRUGBANK Esomeprazole
disease IDO susceptible population
pathway REACTOME Influenza Infection
disease MESH respiratory infections
drug DRUGBANK Hyaluronic acid
drug DRUGBANK Isoxaflutole
disease IDO intervention
disease IDO pathogen
disease MESH uncertainty
disease MESH Acute Stroke
drug DRUGBANK Troleandomycin
drug DRUGBANK Guanosine
disease MESH Coinfection
disease IDO infectivity

Original Article

(Visited 1 times, 1 visits today)